Osaic Holdings
CTOR

Osaic Holdings’s Citius Oncology CTOR Stock Holding History

Osaic Holdings’s Portfolio CTOR Stock Details CTOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$650 Sell
1,000
-9,125
-90% -$7.27K ﹤0.01% 7595
2026
Q1 		$6.28K Sell
10,125
-1,300
-11% -$1.31K ﹤0.01% 6564
2025
Q4 		$11.4K Sell
11,425
-320
-3% -$459 ﹤0.01% 6260
2025
Q3 		$25.2K Buy
11,745
+6,395
+120% +$13.9K ﹤0.01% 5777
2025
Q2 		$23.3K Buy
5,350
+5,000
+1,429% +$5.84K ﹤0.01% 5594
2025
Q1 		$325 Sell
350
-5,130
-94% -$5.5K ﹤0.01% 7087
2024
Q4 		$6.3K Hold
5,480
– – ﹤0.01% 6065
2024
Q3 		$7.62K Buy
+5,480
New +$38.9K ﹤0.01% 5984

Other funds holding CTOR

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Osaic Holdings's CTOR Position: Q2 2026 in Review

Osaic Holdings reduced its Citius Oncology (CTOR) stake by 90% in Q2 2026, selling an estimated $7.27K and leaving 1,000 shares worth $650. The position accounts for ﹤0.01% of the portfolio, ranked #7595.

Osaic Holdings first reported a position in CTOR in Q3 2024 and has held it in 8 quarters since. The position peaked at $25.2K in Q3 2025. 19 funds tracked by Wall St. Rank hold CTOR as of Q2 2026.

  • Osaic Holdings held 1,000 shares of Citius Oncology worth $650 as of Q2 2026.
  • Osaic Holdings sold 9,125 Citius Oncology shares in Q2 2026, an estimated $7.27K.
  • Citius Oncology made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7595 holding.
  • Osaic Holdings first reported a position in Citius Oncology in Q3 2024 and has held it in 8 quarters since.
  • Osaic Holdings's Citius Oncology position peaked at $25.2K in Q3 2025.
  • 19 funds tracked by Wall St. Rank held Citius Oncology as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.